Sunday, 26 July 2026 · World
USD/EUR 0.8788 USD/GBP 0.7507 USD/JPY 163.8 USD/CNY 6.786 All rates →
RSS
EUROS The World Financial Report
Nº 15 Sunday, 26 July 2026 · World Edition
LATEST
Front Page

Vanguard and State Street Growth ETFs Present Divergent Risk and Cost Profiles

EUROS Newsroom · 1h ago · 2 min read
Vanguard and State Street Growth ETFs Present Divergent Risk and Cost Profiles

Investors evaluating growth exposure must choose between the low-cost, tech-heavy concentration of large-cap funds and the diversified, higher-volatility potential of small-cap alternatives.

Market participants are reassessing growth equity allocations as the structural differences between large-cap and small-cap exchange-traded funds become more pronounced. The Vanguard S&P 500 Growth ETF and the State Street SPDR S&P 600 Small Cap Growth ETF represent opposite ends of the market capitalization spectrum, forcing a clear trade-off between stability and expansion potential.

Cost efficiency heavily favors the large-cap option, with the Vanguard fund carrying an expense ratio of 0.07 percent compared to the 0.15 percent fee charged by State Street. Both funds prioritize capital appreciation, though the State Street product offers a slightly higher trailing-12-month yield of 0.7 percent. This reflects a recent distribution of $0.76 per share at a price near $114.58, versus $0.37 per share at approximately $80.29 for the Vanguard fund, yielding 0.4 percent.

Portfolio Concentration vs. Diversification

The Vanguard S&P 500 Growth ETF, launched in 2010, concentrates its 212 holdings heavily in the technology sector, which accounts for 52 percent of the portfolio. Communication services and consumer cyclical stocks make up 16 percent and 9 percent, respectively. This top-heavy structure is evident in its largest positions, with NVIDIA Corp representing 13.64 percent of assets, followed by Microsoft Corp at 7.80 percent and Apple Inc at 5.98 percent.

Conversely, the State Street SPDR S&P 600 Small Cap Growth ETF provides broader diversification across 350 positions. Launched in 2000, the fund maintains a more balanced sector allocation, with industrials at 19 percent, technology at 18 percent, and healthcare at 17 percent. Its top holdings reflect this fragmentation, led by Viasat Inc at 1.15 percent, Corcept Therapeutics Inc at 1.06 percent, and Alkermes Plc at 1.01 percent.

This divergence carries meaningful implications for portfolio construction and risk management. The large-cap fund’s performance is inextricably linked to the fortunes of a few mega-cap technology firms, offering lower relative volatility but higher concentration risk.

Meanwhile, the small-cap alternative introduces higher price volatility relative to the broader market, as measured by beta over a five-year horizon. However, it grants investors exposure to earlier-stage companies with distinct expansion trajectories, insulated from the immediate valuation pressures dominating the largest public equities.